TY  - RPRT
TI  - A phase 3, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of vosoritide in children with hypochondroplasia: CANOPY HCH-3 study design.
AU  - Andrew Dauber
AU  - Ravi Savarirayan
AU  - Ricki Carroll
AU  - Moira Cheung
AU  - Valérie Cormier-Daire
AU  - Mohamad Maghnie
AU  - Noriyuki Namba
AU  - Oliver Semler
AU  - Sajda Ghani
AU  - Ian Sabir
AU  - Roberto Bassi
PY  - 2026
DO  - 10.1177/20420188261480984
UR  - https://pubmed.ncbi.nlm.nih.gov/42694461/
ID  - 42694461
ER  -